Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Using emergency funds to pay off credit card debt can be tempting but may leave you vulnerable. Weigh the pros and cons to make the best decision.
23,601 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Investors are weighing value exposure against high-quality income. This piece analyzes why SCHD may outperform VTV on...
When markets swing, fear can push you to sell at the worst moment. This guide shows practical, actionable steps to tu...
A high-profile venture investor steps away from ETHZilla as Ethereum treasury strategies face a new era. The move spa...
Trump’s renewed push to revive the Rush Hour franchise is drawing investor attention. Analysts say licensing, streami...
US-listed Bitcoin and Ethereum ETFs faced large redemptions through mid-June, yet niche products like Hyperliquid and...
When a crypto exchange missteps, the ripple is felt beyond traders. This article explores why south korean lawmakers ...
A standout move in the world of investing: a wealth manager makes a sizable bet on an active international rotation E...
Regulators scrutinize exchange activity amid sanction challenges. This article breaks down CoinEx's denial, the fund ...
Institutional traders are piling into XRP spot buying while the futures market cools, signaling a pivot in market par...
A real-world move shows an investment advisor trims small-cap exposure by millions, signaling risk management and str...
Floating-rate Treasuries have provided steadier income as rate volatility persists. This piece examines how USFR deli...